Stephan Jakober appointed to the Supervisory Board of MagForce AG


BERLIN, Germany, Oct. 22, 2013 (GLOBE NEWSWIRE) --

MagForce AG (Frankfurt, Xetra: MF6), a
leading medical device company in the area of nanotechnology with a focus on
oncology, today announced details on the change in the Company's Supervisory
Board. Dr Jan zur Hausen stepped back from his membership position on September
13, 2013, due to personal reasons. The county court Berlin-Charlottenburg
appointed Stephan Jakober as new Supervisory Board member.

Stephan Jakober is Chief Financial Officer of Film House Germany AG, a Berlin-
based production company for international and German movies, and works as
consultant vor CIB Beratung AG (Zurich) in the area of Private Equity, Corporate
Finance and Mergers & Acquisition. Prior to that, Stephan Jakober was responsible
for investments in medium-sized enterprises for different European Private
Equity Funds as Investment Director.

Stephan Jakober studied Business Administration at the University of St Gallen
(HSG).

About MagForce AG
MagForce AG is a leading medical device company in the field of nanomedicine in
oncology, listed in the entry standard (MF6). The Company's proprietary,
NanoTherm® therapy, enables the targeted treatment of solid tumors through the
intratumoral generation of heat via activation of superparamagnetic
nanoparticles. NanoTherm®, NanoPlan®, and NanoActivator® are components of
the therapy and have received EU-wide regulatory approval as medical devices for
the treatment of brain tumors. MagForce, NanoTherm®, NanoPlan®, and
NanoActivator® are trademarks of MagForce AG in selected countries. For more
information, please visit www.magforce.com.

Disclaimer
This release may contain forward-looking statements and information which may be
identified by formulations using terms such as "expects", "aims", "anticipates",
"intends", "plans", "believes", "seeks", "estimates" or "will". Such forward-
looking statements are based on our current expectations and certain
assumptions, which may be subject to a variety of risks and uncertainties. The
results actually achieved by MagForce AG may substantially differ from these
forward-looking statements. MagForce AG assumes no obligation to update these
forward-looking statements or to correct them in case of developments, which
differ from those, anticipated.


Contact:
Anne Hennecke
MC Services AG

T +49 89 210228-18
F +49 89 210228-88
M +49 151 12 555 759


Email: anne.hennecke@mc-services.eu


MagForce_Press Release_October 22, 2013: http://hugin.info/143761/R/1737230/582405.pdf

[HUG#1737230]


Tags